Dedalo: Phase II Study of Daratumumab Plus Pomalidomide and Dexamethasone (DPd) in Patients with Relapsed/Refractory Multiple Myeloma and 17p Deletion
In: Blood, Jg. 140 (2022-11-15), Heft Supplement 1, S. 10193-10195
Online
academicJournal
Zugriff:
Titel: |
Dedalo: Phase II Study of Daratumumab Plus Pomalidomide and Dexamethasone (DPd) in Patients with Relapsed/Refractory Multiple Myeloma and 17p Deletion
|
---|---|
Autor/in / Beteiligte Person: | Montefusco, Vittorio ; Cafro, Anna Maria ; Margiotta Casaluci, Gloria ; Patriarca, Francesca ; Mina, Roberto ; D'Agostino, Mattia ; Capra, Andrea ; Priola, Claudia ; Dalla Palma, Anna Benedetta ; Rizzi, Rita ; Genua, Angelo ; Petrucci, Maria Teresa ; Paris, Laura ; Belotti, Angelo ; Cavo, Michele ; Conticello, Concetta ; Carlo-Stella, Carmelo ; Boccadoro, Mario |
Link: | |
Zeitschrift: | Blood, Jg. 140 (2022-11-15), Heft Supplement 1, S. 10193-10195 |
Veröffentlichung: | 2022 |
Medientyp: | academicJournal |
ISSN: | 0006-4971 (electronic) |
DOI: | 10.1182/blood-2022-156691 |
Sonstiges: |
|